Reckitt Continues Asian Push With $724M Paras Purchase
This article was originally published in The Tan Sheet
Executive Summary
Reckitt Benckiser continues expanding its Asian business with the purchase of Paras Pharmaceuticals Ltd., a top OTC manufacturer in India, where nonprescription drug sales are growing 23% annually.